Healthcare Sector Stocks
The Healthcare sector has a total of 1059 stocks, with a combined market cap of $8.4 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.76.
Market Cap
8.4T
Revenue
4.59T
Profits
201.26B
PE Ratio
41.76
Profit Margin
4.39%
Dividend Yield
0.43%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 984.69B | -2.00% | 2,231,282 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 542.53B | -2.35% | 4,838,278 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 383.48B | -0.72% | 2,421,042 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 345.69B | -0.49% | 3,729,198 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 293.34B | -0.93% | 5,089,422 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 288.46B | -0.18% | 1,039,939 | 60.44B |
| 7 | NVS | Novartis AG | 287.62B | -0.52% | 1,077,485 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 202.87B | 0.40% | 8,486,234 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 183.70B | 1.46% | 2,480,872 | 45.20B |
| 10 | AMGN | Amgen Inc. | 181.29B | -0.17% | 920,466 | 37.22B |
| 11 | GILD | Gilead Sciences, Inc. | 166.42B | -1.60% | 3,525,293 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 149.73B | -0.20% | 1,431,974 | 10.58B |
| 13 | ABT | Abbott Laboratories | 149.40B | -0.61% | 6,078,547 | 45.13B |
| 14 | PFE | Pfizer Inc. | 148.87B | -0.08% | 16,169,831 | 63.32B |
| 15 | DHR | Danaher Corporation | 129.39B | 1.21% | 3,634,363 | 24.78B |
| 16 | SYK | Stryker Corporation | 118.23B | 0.25% | 1,949,953 | 25.27B |
| 17 | CVS | CVS Health Corporation | 116.56B | -1.74% | 3,464,587 | 405.62B |
| 18 | BMY | Bristol-Myers Squibb Company | 116.15B | -0.05% | 6,662,740 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 113.30B | -0.35% | 571,002 | 12.22B |
| 20 | SNY | Sanofi | 105.54B | -1.15% | 1,882,781 | 54.60B |
| 21 | GSK | GSK plc | 102.88B | -1.33% | 2,072,564 | 43.29B |
| 22 | MDT | Medtronic plc | 95.08B | -2.00% | 9,519,381 | 35.48B |
| 23 | MCK | McKesson Corporation | 89.62B | -1.50% | 733,967 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 85.63B | 0.40% | 829,872 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 84.19B | -1.27% | 727,299 | 76.39B |
| 26 | CI | The Cigna Group | 73.55B | -2.21% | 707,648 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 72.03B | -1.32% | 22,976,770 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.51B | -1.14% | 922,884 | 14.92B |
| 29 | COR | Cencora, Inc. | 52.62B | 1.02% | 1,562,916 | 328.68B |
| 30 | ARGX | argenx SE | 51.98B | -0.66% | 141,861 | 4.74B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 50.79B | -1.15% | 1,614,520 | 28.34B |
| 32 | EW | Edwards Lifesciences Corporation | 49.83B | 0.67% | 3,653,046 | 6.30B |
| 33 | MDLN | Medline Inc. | 48.30B | -0.08% | 7,544,495 | 29.14B |
| 34 | CAH | Cardinal Health, Inc. | 46.16B | -1.38% | 1,151,175 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.61B | -0.45% | 351,153 | 4.45B |
| 36 | HLN | Haleon plc | 40.67B | -1.41% | 5,971,248 | 14.85B |
| 37 | TEVA | Teva Pharmaceutical Industries Limited | 40.57B | 0.93% | 2,972,709 | 17.35B |
| 38 | BDX | Becton, Dickinson and Company | 40.49B | -0.98% | 1,248,037 | 22.23B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.92B | -1.98% | 563,991 | 4.29B |
| 40 | A | Agilent Technologies, Inc. | 38.30B | 0.24% | 2,235,930 | 7.23B |
| 41 | WAT | Waters Corporation | 37.54B | 4.26% | 1,016,104 | 3.77B |
| 42 | HUM | Humana Inc. | 36.64B | -1.14% | 572,044 | 137.20B |
| 43 | RVMD | Revolution Medicines, Inc. | 33.13B | 0.79% | 3,078,788 | - |
| 44 | ZTS | Zoetis Inc. | 32.63B | -0.55% | 3,807,545 | 9.53B |
| 45 | ALC | Alcon Inc. | 32.16B | 1.55% | 1,991,020 | 10.63B |
| 46 | ONC | BeOne Medicines AG | 32.13B | -0.54% | 105,421 | 5.70B |
| 47 | RPRX | Royalty Pharma plc | 31.68B | 0.97% | 2,690,837 | 2.44B |
| 48 | NTRA | Natera, Inc. | 31.66B | 3.33% | 1,421,602 | 2.50B |
| 49 | IQV | IQVIA Holdings Inc. | 30.59B | 1.22% | 1,176,200 | 16.63B |
| 50 | CNC | Centene Corporation | 29.20B | 0.36% | 2,526,035 | 178.33B |
| 51 | BIIB | Biogen Inc. | 28.86B | -0.48% | 502,472 | 9.94B |
| 52 | VEEV | Veeva Systems Inc. | 28.63B | 6.74% | 2,747,667 | 3.20B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 28.54B | -0.21% | 2,242,627 | 20.98B |
| 54 | DXCM | DexCom, Inc. | 28.45B | 1.92% | 3,645,850 | 4.82B |
| 55 | RMD | ResMed Inc. | 27.85B | -5.63% | 1,791,738 | 5.54B |
| 56 | PHG | Koninklijke Philips N.V. | 25.43B | 0.26% | 675,036 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 24.76B | 3.13% | 1,295,777 | 4.39B |
| 58 | BNTX | BioNTech SE | 24.33B | 2.95% | 838,153 | 3.23B |
| 59 | MTD | Mettler-Toledo International Inc. | 23.86B | 1.48% | 212,403 | 4.09B |
| 60 | UTHR | United Therapeutics Corporation | 23.40B | -1.91% | 283,639 | 3.17B |
| 61 | INSM | Insmed Incorporated | 23.21B | -1.18% | 2,204,981 | 819.56M |
| 62 | WST | West Pharmaceutical Services, Inc. | 22.61B | -0.54% | 567,041 | 3.22B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.63B | -0.42% | 406,049 | 11.28B |
| 64 | ROIV | Roivant Sciences Ltd. | 21.47B | -0.10% | 3,036,442 | 8.26M |
| 65 | LH | Labcorp Holdings Inc. | 21.43B | -0.52% | 264,948 | 14.14B |
| 66 | STE | STERIS plc | 20.78B | -1.62% | 331,643 | 5.94B |
| 67 | INCY | Incyte Corporation | 19.35B | -0.66% | 682,596 | 5.36B |
| 68 | MRNA | Moderna, Inc. | 18.88B | 0.02% | 3,527,402 | 2.23B |
| 69 | VTRS | Viatris Inc. | 18.67B | -0.50% | 5,323,073 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.10B | -3.20% | 2,548,546 | 1.08B |
| 71 | GMAB | Genmab A/S | 16.27B | -2.07% | 1,850,374 | 3.90B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.02B | -0.04% | 1,055,919 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.97B | 1.55% | 536,491 | 3.10B |
| 74 | THC | Tenet Healthcare Corporation | 15.13B | 1.42% | 928,663 | 21.46B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.74B | -0.16% | 997,705 | 4.44B |
| 76 | ASND | Ascendis Pharma A/S | 13.89B | -5.84% | 944,173 | 998.25M |
| 77 | SMMT | Summit Therapeutics Inc. | 13.58B | 0.46% | 4,821,083 | - |
| 78 | SOLV | Solventum Corporation | 13.10B | -0.40% | 1,148,474 | 8.26B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 13.07B | -2.54% | 1,717,379 | 579.96M |
| 80 | MEDP | Medpace Holdings, Inc. | 12.87B | 0.59% | 152,138 | 2.68B |
| 81 | EXEL | Exelixis, Inc. | 12.82B | -0.86% | 1,050,497 | 2.38B |
| 82 | SNN | Smith & Nephew plc | 12.75B | 0.07% | 604,766 | 6.16B |
| 83 | IONS | Ionis Pharmaceuticals, Inc. | 12.71B | -0.57% | 647,475 | 1.06B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 12.69B | 1.46% | 1,752,859 | 13.65B |
| 85 | ALGN | Align Technology, Inc. | 12.60B | 1.59% | 548,661 | 4.10B |
| 86 | PEN | Penumbra, Inc. | 12.53B | -0.11% | 161,489 | 1.45B |
| 87 | DVA | DaVita Inc. | 12.52B | -1.06% | 245,258 | 13.84B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 12.05B | 0.55% | 523,604 | 708.24M |
| 89 | COO | The Cooper Companies, Inc. | 11.97B | 0.49% | 1,990,229 | 4.15B |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.90B | -0.67% | 4,776,084 | 4.89B |
| 91 | RGC | Regencell Bioscience Holdings Limited | 11.84B | -0.90% | 59,159 | - |
| 92 | RVTY | Revvity, Inc. | 11.66B | 3.30% | 1,259,661 | 2.90B |
| 93 | FMS | Fresenius Medical Care AG | 11.66B | 0.14% | 390,954 | 22.32B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.55B | -2.93% | 283,148 | 1.13B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.45B | 0.92% | 763,758 | 3.58B |
| 96 | GMED | Globus Medical, Inc. | 11.16B | -0.31% | 1,130,424 | 3.10B |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.99B | -1.30% | 746,245 | 622.01M |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 10.95B | 7.39% | 2,885,419 | 3.24B |
| 99 | EHC | Encompass Health Corporation | 10.57B | 1.11% | 423,538 | 6.07B |
| 100 | ABVX | ABIVAX Société Anonyme | 10.54B | 1.85% | 1,459,836 | 5.67M |
| 101 | ICLR | ICON Public Limited Company | 10.47B | -0.06% | 1,039,309 | 8.25B |
| 102 | CYTK | Cytokinetics, Incorporated | 10.42B | -0.04% | 1,007,486 | 105.82M |
| 103 | PODD | Insulet Corporation | 9.90B | 0.18% | 912,521 | 2.90B |
| 104 | ENSG | The Ensign Group, Inc. | 9.75B | -1.61% | 300,375 | 5.27B |
| 105 | BAX | Baxter International Inc. | 9.74B | -2.08% | 2,836,173 | 11.32B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 9.53B | -3.04% | 207,352 | 7.46M |
| 107 | MASI | Masimo Corporation | 9.34B | -0.02% | 408,102 | 1.56B |
| 108 | KRYS | Krystal Biotech, Inc. | 9.10B | -0.56% | 118,979 | 417.30M |
| 109 | MOH | Molina Healthcare, Inc. | 9.07B | -2.17% | 452,053 | 43.10B |
| 110 | TEM | Tempus AI, Inc. | 8.99B | -2.36% | 9,706,026 | 1.36B |
| 111 | UHS | Universal Health Services, Inc. | 8.96B | -1.38% | 681,007 | 17.76B |
| 112 | BRKR | Bruker Corporation | 8.89B | 7.41% | 4,524,149 | 3.46B |
| 113 | CRL | Charles River Laboratories International, Inc. | 8.82B | 0.95% | 594,633 | 4.03B |
| 114 | HSIC | Henry Schein, Inc. | 8.79B | 1.07% | 1,430,957 | 13.38B |
| 115 | NUVL | Nuvalent, Inc. | 8.71B | 0.92% | 549,296 | - |
| 116 | BIO | Bio-Rad Laboratories, Inc. | 8.33B | -2.14% | 315,517 | 2.59B |
| 117 | TECH | Bio-Techne Corporation | 8.07B | 1.44% | 1,394,487 | 1.21B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 7.94B | -1.86% | 1,036,788 | 1.51B |
| 119 | IBRX | ImmunityBio, Inc. | 7.76B | -4.02% | 10,883,616 | 140.98M |
| 120 | QGEN | Qiagen N.V. | 7.61B | 0.44% | 1,262,203 | 2.10B |
| 121 | CORT | Corcept Therapeutics Incorporated | 7.46B | 1.64% | 406,540 | 769.10M |
| 122 | ATR | AptarGroup, Inc. | 7.42B | 0.20% | 270,233 | 3.87B |
| 123 | HQY | HealthEquity, Inc. | 7.42B | -2.00% | 1,901,197 | 1.34B |
| 124 | PCVX | Vaxcyte, Inc. | 7.37B | -0.06% | 665,984 | - |
| 125 | ALKS | Alkermes plc | 7.13B | 7.09% | 2,686,781 | 1.56B |
| 126 | RGEN | Repligen Corporation | 7.01B | 1.29% | 417,079 | 763.34M |
| 127 | IMVT | Immunovant, Inc. | 6.80B | -1.07% | 809,005 | - |
| 128 | GRFS | Grifols, S.A. | 6.77B | -0.75% | 482,462 | 8.58B |
| 129 | OSCR | Oscar Health, Inc. | 6.71B | -0.16% | 3,454,197 | 13.30B |
| 130 | KYMR | Kymera Therapeutics, Inc. | 6.69B | -0.09% | 331,350 | 51.48M |
| 131 | CELC | Celcuity Inc. | 6.45B | 1.01% | 917,763 | - |
| 132 | LNTH | Lantheus Holdings, Inc. | 6.45B | -0.59% | 963,664 | 1.55B |
| 133 | PTGX | Protagonist Therapeutics, Inc. | 6.43B | -0.39% | 334,784 | 74.06M |
| 134 | SYRE | Spyre Therapeutics, Inc. | 6.29B | 0.43% | 201,889 | - |
| 135 | AVTR | Avantor, Inc. | 6.27B | 0.33% | 8,358,964 | 6.55B |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 6.15B | 1.29% | 701,346 | 569.61M |
| 137 | CNTA | Centessa Pharmaceuticals plc | 6.15B | -0.15% | 736,348 | 15.00M |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.15B | -3.54% | 295,143 | 217.17M |
| 139 | PTCT | PTC Therapeutics, Inc. | 6.06B | 2.79% | 467,863 | 827.11M |
| 140 | APGE | Apogee Therapeutics, Inc. | 6.04B | 3.62% | 699,554 | - |
| 141 | HIMS | Hims & Hers Health, Inc. | 6.00B | 2.17% | 16,908,775 | 2.37B |
| 142 | GKOS | Glaukos Corporation | 5.98B | -4.31% | 1,029,789 | 551.35M |
| 143 | COGT | Cogent Biosciences, Inc. | 5.94B | -1.79% | 1,191,638 | - |
| 144 | SRRK | Scholar Rock Holding Corporation | 5.90B | -1.20% | 474,019 | - |
| 145 | PACS | PACS Group, Inc. | 5.77B | -4.11% | 603,065 | 5.43B |
| 146 | CHE | Chemed Corporation | 5.72B | -1.62% | 133,001 | 2.54B |
| 147 | TFX | Teleflex Incorporated | 5.71B | -0.52% | 335,375 | 2.13B |
| 148 | BLCO | Bausch + Lomb Corporation | 5.58B | 0.32% | 461,203 | 5.21B |
| 149 | BLTE | Belite Bio, Inc | 5.52B | -5.16% | 457,349 | - |
| 150 | LQDA | Liquidia Corporation | 5.44B | -1.35% | 586,961 | 288.07M |
| 151 | CGON | CG Oncology, Inc. | 5.42B | 1.17% | 531,879 | 5.07M |
| 152 | CRSP | CRISPR Therapeutics AG | 5.41B | -0.48% | 1,472,361 | 4.10M |
| 153 | TGTX | TG Therapeutics, Inc. | 5.41B | -1.70% | 581,299 | 700.35M |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 5.26B | -0.60% | 903,626 | 7.50M |
| 155 | STVN | Stevanato Group S.p.A. | 5.13B | 0.64% | 242,661 | 1.39B |
| 156 | LEGN | Legend Biotech Corporation | 5.01B | -4.46% | 1,772,811 | 1.14B |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 4.93B | -0.74% | 491,831 | 1.34M |
| 158 | CAI | Caris Life Sciences, Inc. | 4.70B | -0.24% | 1,306,095 | 907.29M |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 4.64B | -1.35% | 77,025 | 274.48M |
| 160 | BLLN | BillionToOne, Inc. | 4.53B | 0.71% | 306,862 | 354.54M |
| 161 | SHC | Sotera Health Company | 4.46B | -0.79% | 1,145,955 | 1.19B |
| 162 | RDNT | RadNet, Inc. | 4.37B | 0.45% | 275,206 | 2.14B |
| 163 | HNGE | Hinge Health, Inc. | 4.35B | 2.38% | 1,730,798 | 646.34M |
| 164 | TVTX | Travere Therapeutics, Inc. | 4.35B | -2.05% | 1,099,961 | 536.20M |
| 165 | TWST | Twist Bioscience Corporation | 4.21B | -1.96% | 1,154,220 | 409.48M |
| 166 | AMRX | Amneal Pharmaceuticals, Inc. | 4.17B | 0.93% | 1,110,429 | 3.05B |
| 167 | MANE | Veradermics, Incorporated | 4.09B | -4.93% | 733,994 | - |
| 168 | LIVN | LivaNova PLC | 4.04B | 0.78% | 346,843 | 1.43B |
| 169 | ERAS | Erasca, Inc. | 3.98B | 5.00% | 4,654,380 | - |
| 170 | DOCS | Doximity, Inc. | 3.93B | 1.95% | 2,094,416 | 644.86M |
| 171 | NAMS | NewAmsterdam Pharma Company N.V. | 3.90B | -5.73% | 1,598,948 | 22.57M |
| 172 | NVST | Envista Holdings Corporation | 3.86B | 0.13% | 2,224,726 | 2.81B |
| 173 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.06% | 1,418,948 | 596.96M |
| 174 | WAY | Waystar Holding Corp. | 3.81B | 2.53% | 1,181,192 | 1.16B |
| 175 | VKTX | Viking Therapeutics, Inc. | 3.81B | 1.86% | 1,259,656 | - |
| 176 | MMSI | Merit Medical Systems, Inc. | 3.78B | -0.63% | 356,959 | 1.54B |
| 177 | IRTC | iRhythm Holdings, Inc. | 3.76B | -1.03% | 173,395 | 787.85M |
| 178 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.75B | -1.15% | 1,022,601 | 18.07M |
| 179 | VCYT | Veracyte, Inc. | 3.74B | -2.35% | 556,417 | 541.74M |
| 180 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.72B | -4.82% | 419,344 | 754.05M |
| 181 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | 0.51% | 899,145 | 1.10B |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.66B | 2.19% | 798,193 | - |
| 183 | TXG | 10x Genomics, Inc. | 3.60B | 1.36% | 1,787,047 | 638.78M |
| 184 | OGN | Organon & Co. | 3.51B | 0.19% | 1,150,485 | 6.16B |
| 185 | ORKA | Oruka Therapeutics, Inc. | 3.48B | -0.48% | 762,046 | - |
| 186 | ICUI | ICU Medical, Inc. | 3.42B | -1.56% | 157,782 | 2.16B |
| 187 | DNLI | Denali Therapeutics Inc. | 3.34B | 0.38% | 1,018,246 | - |
| 188 | MMED | MiniMed Group, Inc. | 3.32B | 2.69% | 315,964 | 2.99B |
| 189 | BEAM | Beam Therapeutics Inc. | 3.32B | 1.65% | 817,816 | 164.01M |
| 190 | OPCH | Option Care Health, Inc. | 3.29B | -2.83% | 1,044,469 | 5.67B |
| 191 | CON | Concentra Group Holdings Parent, Inc. | 3.20B | -1.50% | 803,805 | 2.23B |
| 192 | RCUS | Arcus Biosciences, Inc. | 3.18B | 3.43% | 1,499,782 | 236.00M |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.17B | -0.79% | 125,724 | 803.79M |
| 194 | DYN | Dyne Therapeutics, Inc. | 3.17B | 3.18% | 825,575 | - |
| 195 | ALHC | Alignment Healthcare, Inc. | 3.16B | -3.75% | 2,859,423 | 4.26B |
| 196 | GRAL | GRAIL, Inc. | 3.11B | -2.03% | 635,189 | 156.12M |
| 197 | BKD | Brookdale Senior Living Inc. | 3.09B | -0.77% | 1,512,404 | 3.00B |
| 198 | WRBY | Warby Parker Inc. | 3.07B | -2.76% | 1,420,167 | 890.57M |
| 199 | ITGR | Integer Holdings Corporation | 3.06B | 0.09% | 508,535 | 1.86B |
| 200 | HAE | Haemonetics Corporation | 3.06B | 0.30% | 368,089 | 1.33B |
| 201 | TNGX | Tango Therapeutics, Inc. | 3.05B | 5.40% | 1,254,382 | 56.99M |
| 202 | LFST | LifeStance Health Group, Inc. | 3.02B | -0.38% | 1,155,078 | 1.49B |
| 203 | RLAY | Relay Therapeutics, Inc. | 3.02B | -0.43% | 1,574,903 | 10.68M |
| 204 | KLRA | Kailera Therapeutics, Inc. | 2.99B | 0.74% | 352,290 | - |
| 205 | NHC | National HealthCare Corporation | 2.89B | -0.02% | 33,572 | 1.53B |
| 206 | GMRS | GMR Solutions Inc. | 2.79B | -0.16% | 205,254 | 5.74B |
| 207 | GPCR | Structure Therapeutics Inc. | 2.78B | -2.46% | 319,762 | - |
| 208 | HTFL | HeartFlow, Inc. | 2.72B | -0.44% | 511,412 | 191.42M |
| 209 | PRVA | Privia Health Group, Inc. | 2.72B | -0.09% | 459,771 | 2.25B |
| 210 | ALMS | Alumis Inc. | 2.72B | -0.47% | 429,493 | 8.40M |
| 211 | SUPN | Supernus Pharmaceuticals, Inc. | 2.70B | -0.75% | 198,779 | 776.83M |
| 212 | IRON | Disc Medicine, Inc. | 2.67B | -1.42% | 206,416 | - |
| 213 | ARQT | Arcutis Biotherapeutics, Inc. | 2.65B | -1.35% | 794,232 | 415.62M |
| 214 | DFTX | Definium Therapeutics, Inc. | 2.63B | 2.81% | 1,469,582 | - |
| 215 | IDYA | IDEAYA Biosciences, Inc. | 2.60B | 0.82% | 455,803 | 225.27M |
| 216 | MLYS | Mineralys Therapeutics, Inc. | 2.58B | -1.01% | 551,298 | - |
| 217 | TARS | Tarsus Pharmaceuticals, Inc. | 2.54B | -0.67% | 392,919 | 535.08M |
| 218 | VERA | Vera Therapeutics, Inc. | 2.54B | -1.28% | 601,764 | - |
| 219 | IMNM | Immunome, Inc. | 2.49B | -2.53% | 480,411 | 4.02M |
| 220 | CLDX | Celldex Therapeutics, Inc. | 2.47B | -0.76% | 149,615 | 865.00K |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.45B | 0.05% | 306,513 | 1.46B |
| 222 | ADPT | Adaptive Biotechnologies Corporation | 2.43B | -0.20% | 1,144,711 | 295.41M |
| 223 | ELVN | Enliven Therapeutics, Inc. | 2.40B | -2.88% | 454,376 | - |
| 224 | RARE | Ultragenyx Pharmaceutical Inc. | 2.33B | 2.11% | 985,745 | 670.00M |
| 225 | TMDX | TransMedics Group, Inc. | 2.31B | -1.59% | 861,453 | 635.89M |
| 226 | KOD | Kodiak Sciences Inc. | 2.27B | 0.86% | 262,042 | - |
| 227 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.25B | -2.64% | 1,786,753 | 885.72M |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.25B | -2.00% | 357,803 | 1.09B |
| 229 | NKTR | Nektar Therapeutics | 2.18B | -0.78% | 645,447 | 55.63M |
| 230 | LMAT | LeMaitre Vascular, Inc. | 2.17B | 0.37% | 308,952 | 256.28M |
| 231 | ACHC | Acadia Healthcare Company, Inc. | 2.15B | -1.58% | 1,009,695 | 3.37B |
| 232 | CLOV | Clover Health Investments, Corp. | 2.10B | -4.55% | 8,179,880 | 2.21B |
| 233 | XRAY | DENTSPLY SIRONA Inc. | 2.10B | 1.75% | 4,264,210 | 3.68B |
| 234 | PHVS | Pharvaris N.V. | 2.09B | 0.30% | 169,175 | - |
| 235 | HCM | HUTCHMED (China) Limited | 2.08B | 1.69% | 64,274 | 548.51M |
| 236 | AXGN | Axogen, Inc. | 2.07B | -3.65% | 321,895 | 238.11M |
| 237 | ESTA | Establishment Labs Holdings Inc. | 2.05B | -4.37% | 289,130 | 229.58M |
| 238 | SEM | Select Medical Holdings Corporation | 2.05B | - | 498,337 | 5.52B |
| 239 | PGNY | Progyny, Inc. | 2.02B | 0.35% | 569,958 | 1.29B |
| 240 | NBTX | Nanobiotix S.A. | 2.02B | -1.22% | 35,363 | 38.27M |
| 241 | TRVI | Trevi Therapeutics, Inc. | 2.01B | -2.01% | 506,618 | - |
| 242 | OMCL | Omnicell, Inc. | 2.01B | -1.39% | 216,251 | 1.23B |
| 243 | OCUL | Ocular Therapeutix, Inc. | 2.00B | -0.16% | 1,206,175 | 52.04M |
| 244 | MESO | Mesoblast Limited | 1.99B | 4.34% | 108,108 | 65.38M |
| 245 | BHC | Bausch Health Companies Inc. | 1.98B | -1.85% | 1,761,881 | 10.53B |
| 246 | ZLAB | Zai Lab Limited | 1.98B | -4.55% | 619,659 | 453.28M |
| 247 | NVCR | NovoCure Limited | 1.98B | -0.93% | 560,156 | 674.41M |
| 248 | TYRA | Tyra Biosciences, Inc. | 1.97B | 1.53% | 484,118 | - |
| 249 | NTLA | Intellia Therapeutics, Inc. | 1.96B | 2.63% | 4,065,781 | 66.09M |
| 250 | NEOG | Neogen Corporation | 1.96B | -3.33% | 1,581,492 | 870.56M |
| 251 | AUPH | Aurinia Pharmaceuticals Inc. | 1.94B | -1.56% | 606,886 | 298.30M |
| 252 | VRDN | Viridian Therapeutics, Inc. | 1.94B | 0.46% | 644,008 | 70.92M |
| 253 | SION | Sionna Therapeutics, Inc. | 1.93B | -0.05% | 226,747 | - |
| 254 | STOK | Stoke Therapeutics, Inc. | 1.92B | -2.59% | 243,626 | 32.08M |
| 255 | RXRX | Recursion Pharmaceuticals, Inc. | 1.89B | 3.49% | 24,442,910 | 66.41M |
| 256 | RAPP | Rapport Therapeutics, Inc. | 1.88B | -0.28% | 139,881 | 20.00M |
| 257 | ABCL | AbCellera Biologics Inc. | 1.87B | 7.16% | 8,287,695 | 79.21M |
| 258 | ASTH | Astrana Health, Inc. | 1.87B | -1.62% | 184,388 | 3.53B |
| 259 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | 1.97% | 1,882,723 | 2.18B |
| 260 | ADMA | ADMA Biologics, Inc. | 1.86B | 1.26% | 1,392,515 | 509.86M |
| 261 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 0.19% | 90,397 | 1.20B |
| 262 | AAPG | Ascentage Pharma Group International | 1.84B | 0.03% | 15,181 | 82.08M |
| 263 | NRIX | Nurix Therapeutics, Inc. | 1.84B | 0.65% | 537,584 | 71.78M |
| 264 | ZYME | Zymeworks Inc. | 1.84B | -1.18% | 313,339 | 81.26M |
| 265 | HRMY | Harmony Biosciences Holdings, Inc. | 1.82B | -0.35% | 574,652 | 899.11M |
| 266 | NVAX | Novavax, Inc. | 1.79B | 5.52% | 5,032,878 | 596.34M |
| 267 | IOVA | Iovance Biotherapeutics, Inc. | 1.78B | -7.21% | 13,219,252 | 285.61M |
| 268 | QURE | uniQure N.V. | 1.75B | 11.75% | 2,448,582 | 18.09M |
| 269 | SGRY | Surgery Partners, Inc. | 1.75B | -1.17% | 700,986 | 3.34B |
| 270 | PLSE | Pulse Biosciences, Inc. | 1.75B | 2.02% | 127,906 | 751.00K |
| 271 | AGIO | Agios Pharmaceuticals, Inc. | 1.74B | -3.62% | 861,742 | 66.05M |
| 272 | MD | Pediatrix Medical Group, Inc. | 1.74B | 0.46% | 444,081 | 1.93B |
| 273 | CMPS | COMPASS Pathways plc | 1.74B | 8.22% | 3,952,599 | - |
| 274 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -0.71% | 407,196 | 217.17M |
| 275 | UFPT | UFP Technologies, Inc. | 1.73B | -2.11% | 121,254 | 608.85M |
| 276 | SLS | SELLAS Life Sciences Group, Inc. | 1.72B | 0.87% | 20,215,743 | - |
| 277 | CAPR | Capricor Therapeutics, Inc. | 1.72B | 1.89% | 476,209 | 11.13M |
| 278 | VCEL | Vericel Corporation | 1.71B | -2.19% | 189,840 | 292.09M |
| 279 | ADUS | Addus HomeCare Corporation | 1.69B | -1.14% | 80,208 | 1.45B |
| 280 | ANIP | ANI Pharmaceuticals, Inc. | 1.68B | -2.38% | 262,781 | 923.71M |
| 281 | PVLA | Palvella Therapeutics, Inc. | 1.67B | 0.69% | 91,915 | - |
| 282 | GENB | Generate Biomedicines, Inc. | 1.67B | -0.57% | 331,582 | 30.30M |
| 283 | BHVN | Biohaven Ltd. | 1.67B | 8.11% | 3,680,947 | - |
| 284 | TSHA | Taysha Gene Therapies, Inc. | 1.67B | -2.11% | 1,185,391 | 7.47M |
| 285 | ATAI | AtaiBeckley Inc. | 1.66B | 2.72% | 2,869,541 | 3.49M |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.66B | -1.64% | 311,230 | 367.34M |
| 287 | NUVB | Nuvation Bio Inc. | 1.65B | -0.11% | 2,151,609 | 143.05M |
| 288 | GHRS | GH Research PLC | 1.64B | 6.88% | 233,423 | - |
| 289 | GLUE | Monte Rosa Therapeutics, Inc. | 1.63B | -0.26% | 380,684 | 42.95M |
| 290 | ANAB | AnaptysBio, Inc. | 1.62B | -2.30% | 333,767 | 232.39M |
| 291 | VIR | Vir Biotechnology, Inc. | 1.61B | -0.10% | 2,140,570 | 65.50M |
| 292 | INVA | Innoviva, Inc. | 1.58B | -2.15% | 600,473 | 420.69M |
| 293 | AVAH | Aveanna Healthcare Holdings Inc. | 1.57B | -1.71% | 694,952 | 2.52B |
| 294 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.56B | -1.41% | 282,245 | -665.00K |
| 295 | DMRA | Damora Therapeutics, Inc. | 1.55B | 1.61% | 173,557 | - |
| 296 | PGEN | Precigen, Inc. | 1.55B | -3.55% | 3,559,823 | 31.60M |
| 297 | NNNN | Anbio Biotechnology | 1.55B | 2.56% | 6,638 | 8.65M |
| 298 | WGS | GeneDx Holdings Corp. | 1.55B | 4.05% | 764,674 | 442.68M |
| 299 | PRGO | Perrigo Company plc | 1.54B | -2.88% | 1,218,768 | 4.18B |
| 300 | AGL | agilon health, inc. | 1.52B | 0.79% | 146,675 | 5.82B |
| 301 | PRCT | PROCEPT BioRobotics Corporation | 1.52B | -2.13% | 488,020 | 322.02M |
| 302 | IMTX | Immatics N.V. | 1.51B | -1.40% | 197,968 | 43.00M |
| 303 | INBX | Inhibrx Biosciences, Inc. | 1.51B | -0.94% | 149,821 | 1.30M |
| 304 | ARDX | Ardelyx, Inc. | 1.50B | -3.12% | 1,822,766 | 427.68M |
| 305 | STAA | STAAR Surgical Company | 1.48B | 2.54% | 736,162 | 290.38M |
| 306 | MBX | MBX Biosciences, Inc. | 1.47B | -3.20% | 351,922 | - |
| 307 | MAZE | Maze Therapeutics, Inc. | 1.46B | -0.42% | 149,895 | 20.00M |
| 308 | IMCR | Immunocore Holdings plc | 1.45B | -1.55% | 352,393 | 412.81M |
| 309 | ALMR | Alamar Biosciences, Inc. | 1.45B | 5.87% | 240,819 | 87.16M |
| 310 | FTRE | Fortrea Holdings Inc. | 1.43B | 0.90% | 821,894 | 2.71B |
| 311 | HCSG | Healthcare Services Group, Inc. | 1.43B | 0.29% | 412,086 | 1.85B |
| 312 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.13% | 857,488 | 114.48M |
| 313 | AVBP | ArriVent BioPharma, Inc. | 1.41B | 12.50% | 959,670 | - |
| 314 | BCAX | Bicara Therapeutics Inc. | 1.41B | -1.43% | 107,872 | - |
| 315 | ATRC | AtriCure, Inc. | 1.41B | -1.14% | 321,256 | 552.16M |
| 316 | TDOC | Teladoc Health, Inc. | 1.38B | 1.80% | 5,531,520 | 2.51B |
| 317 | MLTX | MoonLake Immunotherapeutics | 1.38B | 1.34% | 778,471 | - |
| 318 | NEO | NeoGenomics, Inc. | 1.38B | 3.93% | 947,763 | 745.97M |
| 319 | URGN | UroGen Pharma Ltd. | 1.36B | -2.84% | 515,021 | 140.49M |
| 320 | MPLT | MapLight Therapeutics, Inc. | 1.35B | 0.27% | 326,088 | - |
| 321 | AHCO | AdaptHealth Corp. | 1.35B | -2.32% | 537,729 | 3.29B |
| 322 | OCS | Oculis Holding AG | 1.34B | -23.41% | 1,519,891 | 1.51M |
| 323 | SEPN | Septerna, Inc. | 1.34B | -4.03% | 145,272 | 72.26M |
| 324 | ARDT | Ardent Health, Inc. | 1.34B | -1.37% | 138,589 | 6.43B |
| 325 | AHG | Akso Health Group | 1.34B | 1.30% | 4,302 | 14.84M |
| 326 | SVRA | Savara Inc. | 1.31B | 1.28% | 790,795 | - |
| 327 | ENOV | Enovis Corporation | 1.30B | -1.82% | 372,357 | 2.28B |
| 328 | HROW | Harrow, Inc. | 1.30B | -1.55% | 644,499 | 268.68M |
| 329 | WVE | Wave Life Sciences Ltd. | 1.27B | 1.85% | 1,316,844 | 71.80M |
| 330 | IART | Integra LifeSciences Holdings Corporation | 1.26B | -1.34% | 403,715 | 1.64B |
| 331 | COAG | Hemab Therapeutics Holdings, Inc. | 1.26B | 1.79% | 87,824 | - |
| 332 | PAHC | Phibro Animal Health Corporation | 1.25B | -3.05% | 142,912 | 1.50B |
| 333 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.25B | 4.09% | 2,063,471 | 204.73M |
| 334 | KMTS | Kestra Medical Technologies, Ltd. | 1.23B | -0.52% | 94,555 | 83.72M |
| 335 | BLFS | BioLife Solutions, Inc. | 1.23B | -0.20% | 343,958 | 101.66M |
| 336 | AVLN | Avalyn Pharma Inc. | 1.22B | 2.87% | 186,729 | - |
| 337 | INSP | Inspire Medical Systems, Inc. | 1.20B | -3.00% | 531,824 | 915.25M |
| 338 | ATEC | Alphatec Holdings, Inc. | 1.19B | -1.58% | 1,405,194 | 787.08M |
| 339 | PNTG | The Pennant Group, Inc. | 1.19B | -0.23% | 108,470 | 1.02B |
| 340 | PSNL | Personalis, Inc. | 1.19B | 3.46% | 3,066,212 | 64.52M |
| 341 | CDNA | CareDx, Inc. | 1.18B | 0.84% | 362,223 | 412.82M |
| 342 | MNKD | MannKind Corporation | 1.17B | 4.26% | 16,080,077 | 360.78M |
| 343 | BFLY | Butterfly Network, Inc. | 1.17B | -2.82% | 1,891,061 | 102.92M |
| 344 | TNDM | Tandem Diabetes Care, Inc. | 1.17B | 2.27% | 1,855,708 | 1.03B |
| 345 | IRMD | IRADIMED CORPORATION | 1.17B | -0.96% | 117,376 | 86.28M |
| 346 | AVNS | Avanos Medical, Inc. | 1.16B | 0.08% | 336,113 | 715.90M |
| 347 | ZBIO | Zenas BioPharma, Inc. | 1.16B | -1.29% | 259,510 | 10.00M |
| 348 | AKTS | Aktis Oncology, Inc. | 1.16B | 2.40% | 86,741 | 8.28M |
| 349 | OLMA | Olema Pharmaceuticals, Inc. | 1.14B | 2.59% | 804,128 | - |
| 350 | EYPT | EyePoint, Inc. | 1.14B | 0.52% | 570,487 | 7.61M |
| 351 | SDGR | Schrödinger, Inc. | 1.13B | 6.99% | 1,597,453 | 254.91M |
| 352 | AMN | AMN Healthcare Services, Inc. | 1.13B | 4.01% | 669,798 | 3.42B |
| 353 | DBVT | DBV Technologies S.A. | 1.11B | 0.11% | 251,715 | 5.74M |
| 354 | OPK | OPKO Health, Inc. | 1.11B | 2.45% | 1,948,048 | 581.12M |
| 355 | EVO | Evotec SE | 1.10B | 3.38% | 22,070 | 859.03M |
| 356 | AORT | Artivion, Inc. | 1.09B | -0.44% | 348,573 | 458.69M |
| 357 | COLL | Collegium Pharmaceutical, Inc. | 1.08B | - | 257,749 | 796.33M |
| 358 | OMDA | Omada Health, Inc. | 1.08B | 1.88% | 931,453 | 283.30M |
| 359 | CNMD | CONMED Corporation | 1.07B | 0.11% | 154,856 | 1.37B |
| 360 | XERS | Xeris Biopharma Holdings, Inc. | 1.07B | -2.37% | 1,250,135 | 314.85M |
| 361 | AZTA | Azenta, Inc. | 1.06B | 2.67% | 960,912 | 596.48M |
| 362 | CRON | Cronos Group Inc. | 1.06B | -0.53% | 1,113,759 | 159.54M |
| 363 | ALVO | Alvotech | 1.06B | -1.60% | 543,778 | 562.04M |
| 364 | ABSI | Absci Corporation | 1.06B | 11.35% | 8,188,515 | 1.84M |
| 365 | IVA | Inventiva S.A. | 1.04B | -5.45% | 55,981 | 7.94M |
| 366 | JBIO | Jade Biosciences, Inc. | 1.04B | 0.82% | 381,097 | - |
| 367 | CRVS | Corvus Pharmaceuticals, Inc. | 1.03B | -1.68% | 1,476,273 | - |
| 368 | INNV | InnovAge Holding Corp. | 1.03B | 1.33% | 160,450 | 949.17M |
| 369 | CGEM | Cullinan Therapeutics, Inc. | 998.69M | 5.79% | 1,366,046 | - |
| 370 | GDRX | GoodRx Holdings, Inc. | 992.32M | -1.35% | 1,533,182 | 787.89M |
| 371 | MGTX | MeiraGTx Holdings plc | 980.73M | 5.90% | 932,775 | 79.76M |
| 372 | USPH | U.S. Physical Therapy, Inc. | 976.74M | 0.45% | 110,459 | 787.69M |
| 373 | DRTS | Alpha Tau Medical Ltd. | 974.35M | 6.66% | 1,115,189 | - |
| 374 | LXRX | Lexicon Pharmaceuticals, Inc. | 965.92M | -1.58% | 1,185,111 | 69.64M |
| 375 | SPTX | Seaport Therapeutics, Inc. | 963.52M | -3.35% | 81,673 | - |
| 376 | PHAR | Pharming Group N.V. | 949.84M | -0.13% | 10,067 | 369.49M |
| 377 | PCRX | Pacira BioSciences, Inc. | 923.10M | -0.93% | 151,409 | 734.86M |
| 378 | CERT | Certara, Inc. | 918.61M | 4.14% | 2,139,037 | 419.75M |
| 379 | NUTX | Nutex Health Inc. | 913.98M | 1.72% | 56,898 | 879.95M |
| 380 | SPRY | ARS Pharmaceuticals, Inc. | 912.60M | -2.23% | 1,424,995 | 98.99M |
| 381 | SANA | Sana Biotechnology, Inc. | 907.23M | 4.15% | 3,019,783 | - |
| 382 | KURA | Kura Oncology, Inc. | 906.83M | 2.46% | 1,236,209 | 71.64M |
| 383 | ABUS | Arbutus Biopharma Corporation | 900.77M | -0.87% | 1,397,561 | 191.45M |
| 384 | JANX | Janux Therapeutics, Inc. | 885.49M | -1.49% | 680,434 | 13.73M |
| 385 | QDEL | QuidelOrtho Corporation | 884.44M | -0.77% | 808,285 | 2.66B |
| 386 | XNCR | Xencor, Inc. | 883.03M | -0.50% | 320,272 | 97.36M |
| 387 | INMD | InMode Ltd. | 880.69M | -1.07% | 518,171 | 374.64M |
| 388 | ORIC | ORIC Pharmaceuticals, Inc. | 877.83M | 0.36% | 3,076,128 | - |
| 389 | ANNX | Annexon, Inc. | 877.38M | -0.28% | 1,319,816 | - |
| 390 | DRUG | Bright Minds Biosciences Inc. | 872.67M | -1.84% | 187,183 | - |
| 391 | TALK | Talkspace, Inc. | 870.23M | 0.10% | 2,365,951 | 238.37M |
| 392 | AVR | Anteris Technologies Global Corp. | 859.15M | -2.85% | 555,331 | 1.85M |
| 393 | ETON | Eton Pharmaceuticals, Inc. | 830.54M | -4.83% | 208,301 | 86.93M |
| 394 | TBPH | Theravance Biopharma, Inc. | 829.49M | -0.74% | 287,297 | 109.78M |
| 395 | AVTX | Avalo Therapeutics, Inc. | 829.48M | -2.17% | 702,828 | 59.00K |
| 396 | AMPH | Amphastar Pharmaceuticals, Inc. | 826.30M | -2.90% | 500,076 | 720.53M |
| 397 | AURA | Aura Biosciences, Inc. | 825.04M | -0.27% | 218,415 | - |
| 398 | EVMN | Evommune, Inc. | 819.24M | -2.51% | 121,385 | 10.00M |
| 399 | ODTX | Odyssey Therapeutics, Inc. | 812.81M | -3.85% | 113,262 | 2.98M |
| 400 | VOR | Vor Biopharma Inc. | 811.16M | -0.27% | 297,334 | - |
| 401 | LBRX | LB Pharmaceuticals Inc | 807.06M | 2.23% | 92,456 | - |
| 402 | ESPR | Esperion Therapeutics, Inc. | 805.76M | - | 4,521,139 | 418.24M |
| 403 | GERN | Geron Corporation | 805.11M | 0.40% | 7,071,093 | 196.12M |
| 404 | SSII | SS Innovations International, Inc. | 791.76M | 0.25% | 37,893 | 48.47M |
| 405 | OMER | Omeros Corporation | 788.89M | -2.24% | 905,881 | 9.89M |
| 406 | CTMX | CytomX Therapeutics, Inc. | 773.93M | -4.18% | 1,435,406 | 35.54M |
| 407 | PHAT | Phathom Pharmaceuticals, Inc. | 764.12M | -6.78% | 1,051,183 | 204.89M |
| 408 | BIOA | BioAge Labs, Inc. | 762.36M | 0.59% | 159,712 | 10.32M |
| 409 | LMRI | Lumexa Imaging Holdings, Inc. | 746.55M | 0.91% | 392,550 | 1.03B |
| 410 | RLMD | Relmada Therapeutics, Inc. | 745.76M | -1.93% | 439,628 | - |
| 411 | ALLO | Allogene Therapeutics, Inc. | 745.53M | -4.00% | 7,835,332 | 22.00K |
| 412 | HSTM | HealthStream, Inc. | 734.32M | 2.05% | 184,445 | 311.78M |
| 413 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 729.78M | 3.05% | 193,029 | - |
| 414 | BVS | Bioventus Inc. | 718.40M | -3.04% | 500,229 | 576.30M |
| 415 | SLDB | Solid Biosciences Inc. | 716.71M | 2.97% | 748,808 | - |
| 416 | REPL | Replimune Group, Inc. | 714.25M | 84.83% | 48,318,558 | - |
| 417 | ANRO | Alto Neuroscience, Inc. | 708.77M | - | 103,134 | - |
| 418 | CBLL | CeriBell, Inc. | 701.18M | -1.02% | 61,483 | 95.07M |
| 419 | TENX | Tenax Therapeutics, Inc. | 690.64M | 0.34% | 275,733 | - |
| 420 | CBIO | Crescent Biopharma, Inc. | 684.19M | -4.10% | 323,249 | 11.88M |
| 421 | ZVRA | Zevra Therapeutics, Inc. | 683.37M | 1.40% | 1,571,348 | 122.29M |
| 422 | CRMD | CorMedix Inc. | 657.43M | -0.48% | 674,528 | 400.05M |
| 423 | TLRY | Tilray Brands, Inc. | 656.65M | -2.57% | 2,656,015 | 858.28M |
| 424 | DSGN | Design Therapeutics, Inc. | 652.05M | -2.79% | 1,078,238 | - |
| 425 | SGP | SpyGlass Pharma, Inc. | 645.30M | -2.70% | 33,771 | - |
| 426 | CSTL | Castle Biosciences, Inc. | 639.36M | -4.66% | 164,763 | 339.92M |
| 427 | PRME | Prime Medicine, Inc. | 633.97M | 3.24% | 2,420,336 | 4.03M |
| 428 | BWAY | BrainsWay Ltd. | 633.64M | -1.07% | 48,301 | 56.22M |
| 429 | ACRS | Aclaris Therapeutics, Inc. | 630.58M | -1.20% | 555,770 | 8.37M |
| 430 | SIBN | SI-BONE, Inc. | 627.54M | -1.80% | 347,802 | 206.22M |
| 431 | CERS | Cerus Corporation | 621.14M | 6.16% | 2,116,141 | 216.56M |
| 432 | CABA | Cabaletta Bio, Inc. | 614.72M | - | 1,666,784 | - |
| 433 | PHR | Phreesia, Inc. | 612.56M | 4.87% | 1,633,620 | 495.59M |
| 434 | IMMX | Immix Biopharma, Inc. | 611.37M | -0.90% | 517,708 | - |
| 435 | DNA | Ginkgo Bioworks Holdings, Inc. | 608.82M | -1.48% | 771,742 | 151.40M |
| 436 | CADL | Candel Therapeutics, Inc. | 607.41M | 2.47% | 983,472 | - |
| 437 | VALN | Valneva SE | 590.53M | -0.63% | 48,533 | 180.25M |
| 438 | TECX | Tectonic Therapeutic, Inc. | 590.42M | 5.07% | 234,676 | - |
| 439 | ALT | Altimmune, Inc. | 590.23M | -1.14% | 1,418,268 | 36.00K |
| 440 | IRWD | Ironwood Pharmaceuticals, Inc. | 586.02M | -1.11% | 1,338,264 | 361.51M |
| 441 | EIKN | Eikon Therapeutics, Inc. | 583.07M | 4.56% | 161,503 | - |
| 442 | ARVN | Arvinas, Inc. | 576.50M | 1.07% | 520,034 | 89.40M |
| 443 | NPCE | NeuroPace, Inc. | 573.12M | -3.34% | 85,705 | 99.53M |
| 444 | RIGL | Rigel Pharmaceuticals, Inc. | 560.61M | 0.83% | 205,930 | 299.77M |
| 445 | TCMD | Tactile Systems Technology, Inc. | 558.38M | -3.11% | 140,729 | 343.52M |
| 446 | AGMB | AgomAb Therapeutics NV | 557.49M | -1.91% | 15,864 | - |
| 447 | TRAX | First Tracks Biotherapeutics, Inc. | 549.90M | -0.38% | 234,845 | - |
| 448 | PROK | ProKidney Corp. | 549.75M | 0.55% | 796,933 | 889.00K |
| 449 | MDXG | MiMedx Group, Inc. | 549.61M | 0.54% | 630,168 | 389.42M |
| 450 | ASMB | Assembly Biosciences, Inc. | 549.33M | -0.04% | 67,895 | 71.10M |
| 451 | CTKB | Cytek Biosciences, Inc. | 545.63M | 2.55% | 557,355 | 204.17M |
| 452 | SRTA | Strata Critical Medical, Inc. | 543.39M | -2.94% | 483,983 | 228.58M |
| 453 | ACHV | Achieve Life Sciences, Inc. | 543.07M | -0.19% | 764,434 | - |
| 454 | GYRE | Gyre Therapeutics, Inc. | 539.09M | 2.79% | 49,097 | 117.05M |
| 455 | BBNX | Beta Bionics, Inc. | 535.19M | -0.74% | 254,243 | 110.24M |
| 456 | PRTA | Prothena Corporation plc | 529.29M | 1.30% | 289,478 | 57.94M |
| 457 | FLGT | Fulgent Genetics, Inc. | 525.41M | 1.43% | 232,020 | 320.35M |
| 458 | EDIT | Editas Medicine, Inc. | 524.07M | -0.44% | 2,786,242 | 38.69M |
| 459 | XOMA | XOMA Royalty Corporation | 523.27M | 0.06% | 43,376 | 48.56M |
| 460 | CLYM | Climb Bio, Inc. | 521.15M | -3.79% | 328,649 | - |
| 461 | FDMT | 4D Molecular Therapeutics, Inc. | 517.53M | 10.37% | 3,044,273 | 88.24M |
| 462 | KYTX | Kyverna Therapeutics, Inc. | 515.11M | -1.62% | 456,399 | - |
| 463 | AQST | Aquestive Therapeutics, Inc. | 504.94M | 0.12% | 926,615 | 50.27M |
| 464 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 465 | CTNM | Contineum Therapeutics, Inc. | 501.73M | 0.83% | 73,066 | - |
| 466 | AUTL | Autolus Therapeutics plc | 495.03M | 5.08% | 2,075,882 | 92.62M |
| 467 | EPRX | Eupraxia Pharmaceuticals Inc. | 482.67M | -2.85% | 167,073 | - |
| 468 | ANGO | AngioDynamics, Inc. | 480.59M | -2.21% | 120,633 | 313.73M |
| 469 | STRO | Sutro Biopharma, Inc. | 478.65M | -2.50% | 103,247 | 102.48M |
| 470 | WEAV | Weave Communications, Inc. | 478.19M | 4.34% | 677,070 | 248.72M |
| 471 | CCCC | C4 Therapeutics, Inc. | 475.98M | 18.03% | 5,006,472 | 34.86M |
| 472 | EBS | Emergent BioSolutions Inc. | 472.62M | -0.22% | 848,730 | 676.80M |
| 473 | ANL | Adlai Nortye Ltd. | 469.20M | 3.81% | 91,823 | 5.00M |
| 474 | OVID | Ovid Therapeutics Inc. | 467.20M | 2.27% | 1,279,874 | 7.12M |
| 475 | OCGN | Ocugen, Inc. | 465.47M | -2.48% | 11,827,083 | 4.47M |
| 476 | FBRX | Forte Biosciences, Inc. | 461.83M | -9.00% | 308,149 | - |
| 477 | FULC | Fulcrum Therapeutics, Inc. | 459.77M | 1.17% | 237,825 | 80.00M |
| 478 | PACB | Pacific Biosciences of California, Inc. | 459.69M | 0.68% | 5,511,722 | 160.03M |
| 479 | UPB | Upstream Bio, Inc. | 457.13M | 0.96% | 266,723 | 3.32M |
| 480 | TOI | The Oncology Institute, Inc. | 455.92M | -3.18% | 862,436 | 545.76M |
| 481 | KMDA | Kamada Ltd. | 455.27M | -0.61% | 28,090 | 181.68M |
| 482 | STTK | Shattuck Labs, Inc. | 453.18M | -1.01% | 771,674 | 1.00M |
| 483 | EVH | Evolent Health, Inc. | 450.49M | 2.69% | 2,113,792 | 1.89B |
| 484 | LAB | Standard BioTools Inc. | 448.92M | 0.88% | 1,878,870 | 86.26M |
| 485 | NRC | NRC Health | 448.71M | 1.27% | 60,128 | 138.64M |
| 486 | CATX | Perspective Therapeutics, Inc. | 448.20M | -2.96% | 545,828 | 618.00K |
| 487 | SGMT | Sagimet Biosciences Inc. | 447.70M | -0.28% | 316,571 | - |
| 488 | NGNE | Neurogene Inc. | 445.46M | 2.51% | 39,096 | 925.00K |
| 489 | KIDS | OrthoPediatrics Corp. | 439.47M | -3.93% | 76,017 | 243.30M |
| 490 | CTEV | Claritev Corporation | 435.91M | 4.11% | 66,984 | 978.76M |
| 491 | MNPR | Monopar Therapeutics Inc. | 433.75M | 0.50% | 104,727 | - |
| 492 | EOLS | Evolus, Inc. | 433.32M | 0.15% | 454,368 | 301.79M |
| 493 | VREX | Varex Imaging Corporation | 433.27M | -2.28% | 209,649 | 857.50M |
| 494 | CMPX | Compass Therapeutics, Inc. | 432.21M | -0.41% | 3,747,428 | 850.00K |
| 495 | ADCT | ADC Therapeutics SA | 431.18M | -1.74% | 309,505 | 79.18M |
| 496 | IPSC | Century Therapeutics, Inc. | 428.34M | -0.42% | 664,448 | 109.16M |
| 497 | CGC | Canopy Growth Corporation | 424.81M | -4.02% | 6,932,412 | 203.04M |
| 498 | MOBI | Mobia Medical, Inc. | 423.49M | -1.54% | 44,405 | 32.04M |
| 499 | XFOR | X4 Pharmaceuticals, Inc. | 408.40M | 4.59% | 711,867 | 9.01M |
| 500 | CCRN | Cross Country Healthcare, Inc. | 405.59M | -0.08% | 248,221 | 1.00B |